tiprankstipranks
AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
US Market
ANTX
AN2 Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see ANTX full AI Analyst Report?

AN2 Therapeutics, Inc. (ANTX) Ownership - Who Owns AN2 Therapeutics, Inc.?

106 Followers

AN2 Therapeutics, Inc. (ANTX) Ownership Overview

26.56%3.35%11.56%2.97%55.56%
26.56% Insiders
3.35% Mutual Funds
11.56% Other Institutional Investors
2.97% ETFs
55.56% Public Companies and
Individual Investors
The ownership structure of AN2 Therapeutics, Inc. (ANTX) stock is a mix of institutional, retail, and individual investors. Approximately 17.88% of the company’s stock is owned by Institutional Investors, 26.56% is owned by Insiders, and 55.56% is owned by Public Companies and Individual Investors.
The ownership structure of AN2 Therapeutics, Inc. (ANTX) stock is a mix of institutional, retail, and individual investors. Approximately 14.91% of the company’s stock is owned by Institutional Investors, 26.56% is owned by Insiders, and 2.97% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 05, 2026
Sarah Joanne Williams
xxxxxxxxxxxxx
$347
Jan 07, 2026
Eizen Joshua M
xxxxxxxxxxxxx
$24923
Jan 07, 2026
Stephen David Prior
xxxxxxxxxxxxx
$6491
Jun 16, 2025
Braden Michael Leonard
xxxxxxxxxxxxx
$218000
Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2023
Woodline Partners Lp
xxxxxxxxxxxxx
$166407
Show More Hedge Fund Trading Activity >

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,017,432Insider8.39%13,095,655
2,429,754Insider6.76%10,545,132
1,628,512Insider4.53%7,067,742
1,243,938Insider3.46%5,398,691
985,504Institution2.74%4,277,087
935,028Institution2.60%4,058,022
551,418Insider1.53%2,393,154
207,543Institution0.58%900,737
207,499Insider0.58%900,546
Michael Rockefeller
145,971Institution0.41%633,514

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
935,028Institution2.60%4,058,022
207,543Institution0.58%900,737
59,000Institution0.16%256,060
1,347Institution<0.01%5,846

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
Vanguard Total Stock Market ETF
733,392Institution2.04%2,508,201
Vanguard Extended Market ETF
252,112Institution0.70%862,223
iShares Micro-Cap ETF
53,515Institution0.15%232,255
Dimensional U.S. Small Cap ETF
26,415Institution0.07%113,056
Dimensional U.S. Core Equity 2 ETF
3,416Institution<0.01%14,620

FAQ

Who Owns AN2 Therapeutics, Inc. (ANTX)?
According to the latest TipRanks data, approximately 11.56% of the company's stock is held by institutional investors, 26.56% is held by insiders, and 55.56% is held by retail investors.
    What percentage of AN2 Therapeutics, Inc. (ANTX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 11.56% of AN2 Therapeutics, Inc. (ANTX) stock is held by institutional investors.
      What percentage of AN2 Therapeutics, Inc. (ANTX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 55.56% of AN2 Therapeutics, Inc. (ANTX) stock is held by retail investors.
        Who owns the most shares of AN2 Therapeutics, Inc. (ANTX)?
        Braden Michael Leonard owns the most shares of AN2 Therapeutics, Inc. (ANTX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.